Lipid-Nanoparticles for RNA-based In-Vivo Applications or Ex-Vivo Immune Cell Modifications
The ITRI-LNP platform, which features proprietary ionizable lipids tailored for effectively delivering nucleic acids to target cells. Demonstrating superior transfection in mice and human immune cells, our technology can load a variety of nucleic acids for drug development targeting various conditions such as cancers, infectious diseases, and rare diseases. ITRI-LNPs can also serve as an alternative tool for immune cell engineering, showcasing the broad medical applications.
ITRI is a world-leading applied technology research institute with more than 6,000 outstanding employees. Its mission is to drive industrial development, create economic value, and enhance social well-being through technology R&D. Founded in 1973, it pioneered in IC development and started to nurture new tech ventures and deliver its R&D results to industries. ITRI has set up and incubated companies such as TSMC, UMC, Taiwan Mask Corp., Epistar Corp., Mirle Automation Corp., and Taiwan Biomaterial Co.
Name：
Phone：
Address：195, Sec. 4, Chung Hsing Rd., Chutung, Hsinchu, Taiwan 31040, R.O.C.
Ultrahigh-Sensitive Detection Platform Powered by Semiconductor-based Biosensor for the evaluation of Treatment on Acute Myeloid Leukemia
A Wearable and Self-powered Multifunctional Module for Active Infectio n Prevention, Accelerated Wound Healing and Noninvasive Healing Moni toring
Bioinspired iKNOBEADS as Ancillary Materials for Next-Generation Cell Immunotherapy
Advanced Imaging and Detection Technology for Large-Scale Blood Circulation: Blood Circulation Imaging System
Technology maturity：Experiment stage
Exhibiting purpose：Technology transactions、Patent transactions、Product promotion、Display of scientific results
Trading preferences：New products development、Technical license/cooperation、Exclusive license/assignment
*Organization
*Name
*Phone
*Main Purpose
*Discuss Further
*Job Category
*Overall Rating
*Favorite Area
*Key Tech Focus
*Willing to Receive Updates?
Other Suggestions
Coming soon!